Premium
Complementary roles for lipid and protein allergens in triggering innate and adaptive immune systems
Author(s) -
Russano A. M.,
Agea E.,
Casciari C.,
De Benedictis F. M.,
Spinozzi F.
Publication year - 2008
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.2008.01810.x
Subject(s) - innate immune system , immunology , acquired immune system , immune system , biology
Background: Recent advances in allergy research mostly focussed on two major headings: improving protein allergen purification, which is aimed towards a better characterization of IgE‐ and T‐cell reactive epitopes, and the potential new role for unconventional innate and regulatory T cells in controlling airway inflammation. These advancements could appear to be in conflict each other, as innate T cells have a poorly‐defined antigen specificity that is often directed toward nonprotein substances, such as lipids. Method: To reconcile these contrasting findings, the model of cypress pollinosis as paradigmatic for studying allergic diseases in adults is suggested. Results: The biochemical characterization of major native protein allergens from undenatured pollen grain demonstrated that the most relevant substance with IgE‐binding activity is a glycohydrolase enzyme, which easily denaturizes in stored grains. Moreover, lipids from the pollen membrane are implicated in early pollen grain capture and recognition by CD1 + dendritic cells (DC) and CD1‐restricted T lymphocytes. These T cells display Th0/Th2 functional activity and are also able to produce regulatory cytokines, such as IL‐10 and TGF‐β. CD1 + immature DCs expand in the respiratory mucosa of allergic subjects and are able to process both proteins and lipids. Conclusion: A final scenario may suggest that expansion and functional activation of CD1 + DCs is a key step for mounting a Th0/Th2‐deviated immune response, and that such innate response does not confer long‐lasting protective immunity.